Biotronik Atrial Leadless ICD Line Scores FDA Approval

The FDA has approved Biotronik’s Intica DX and Intica CRT-DX implantable defibrillator systems.

The German company’s Intica device line is the first that does not require an atrial lead because it provides atrial signal information. The systems remove several of the risks and complications associated with implanting cardiac resynchronization therapy devices.

The new device also incorporates the company’s MultiPole Pacing technology, which allows two pacings per cardiac cycle for the left ventricle.